Sublingual immunization with an HIV subunit vaccine induces antibodies and cytotoxic T cells in the mouse female genital tract

Vaccine. 2010 Aug 2;28(34):5582-90. doi: 10.1016/j.vaccine.2010.06.033. Epub 2010 Jun 25.

Abstract

A vaccine against heterosexual transmission by human immunodeficiency virus (HIV) should generate cytotoxic and antibody responses in the female genital tract and in extra-genital organs. We report that sublingual immunization with HIV-1 gp41 and a reverse transcriptase polypeptide coupled to the cholera toxin B subunit (CTB) induced gp41-specific IgA antibodies and antibody-secreting cells, as well as reverse transcriptase-specific CD8 T cells in the genital mucosa, contrary to intradermal immunization. Conjugation of the reverse transcriptase peptide to CTB favored its cross-presentation by human dendritic cells to a T cell line from an HIV(+) patient. Sublingual vaccination could represent a promising vaccine strategy against heterosexual transmission of HIV-1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AIDS Vaccines / immunology*
  • Administration, Sublingual
  • Animals
  • Cross-Priming
  • Dendritic Cells / immunology
  • Female
  • Genitalia, Female / immunology*
  • Genitalia, Female / virology
  • HIV Antibodies / immunology*
  • HIV Envelope Protein gp41 / immunology
  • HIV Infections / immunology
  • HIV Infections / prevention & control*
  • Humans
  • Immunoglobulin A / immunology
  • Immunoglobulin G / immunology
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Mucous Membrane / immunology
  • T-Lymphocytes, Cytotoxic / immunology*

Substances

  • AIDS Vaccines
  • HIV Antibodies
  • HIV Envelope Protein gp41
  • Immunoglobulin A
  • Immunoglobulin G
  • gp41 protein, Human immunodeficiency virus 1